Literature DB >> 16177084

Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation.

Motoi Maeda1, Carmine Carpenito, Ryan C Russell, Jyoti Dasanjh, Linnea L Veinotte, Hideaki Ohta, Takashi Yamamura, Rusung Tan, Fumio Takei.   

Abstract

Human and mouse NK cells use different families of receptors to recognize MHC class I (MHC I) on target cells. Although human NK cells express both Ig-like receptors and lectin-like receptors specific for MHC I, all the MHC I-specific receptors identified on mouse NK cells to date are lectin-like receptors, and no Ig-like receptors recognizing MHC I have been identified on mouse NK cells. In this study we report the first MHC I-specific Ig-like receptor on mouse NK cells, namely, murine CD160 (mCD160). The expression of mCD160 is restricted to a subset of NK cells, NK1.1+ T cells, and activated CD8+ T cells. The mCD160-Ig fusion protein binds to rat cell lines transfected with classical and nonclassical mouse MHC I, including CD1d. Furthermore, the level of mCD160 on NK1.1+ T cells is modulated by MHC I of the host. Overexpression of mCD160 in the mouse NK cell line KY-2 inhibits IFN-gamma production induced by phorbol ester plus ionomycin, whereas it enhances IFN-gamma production induced by NK1.1 cross-linking or incubation with dendritic cells. Cross-linking of mCD160 also inhibits anti-NK1.1-mediated stimulation of KY-2 cells. Anti-mCD160 mAb alone has no effect. Thus, mCD160, the first MHC I-specific Ig-like receptor on mouse NK cells, regulates NK cell activation both positively and negatively, depending on the stimulus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177084     DOI: 10.4049/jimmunol.175.7.4426

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  Update on hepatitis C virus-specific immunity.

Authors:  Donatella Ciuffreda; Arthur Y Kim
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

2.  Structural Basis of CD160:HVEM Recognition.

Authors:  Weifeng Liu; Sarah C Garrett; Elena V Fedorov; Udupi A Ramagopal; Scott J Garforth; Jeffrey B Bonanno; Steven C Almo
Journal:  Structure       Date:  2019-06-20       Impact factor: 5.006

Review 3.  Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.

Authors:  Marcos W Steinberg; Jr-Wen Shui; Carl F Ware; Mitchell Kronenberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

Review 4.  The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.

Authors:  Marcos W Steinberg; Timothy C Cheung; Carl F Ware
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

5.  HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria.

Authors:  Jr-Wen Shui; Alexandre Larange; Gisen Kim; Jose Luis Vela; Sonja Zahner; Hilde Cheroutre; Mitchell Kronenberg
Journal:  Nature       Date:  2012-08-09       Impact factor: 49.962

Review 6.  Tumor necrosis factor superfamily in innate immunity and inflammation.

Authors:  John Šedý; Vasileios Bekiaris; Carl F Ware
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-18       Impact factor: 10.005

7.  Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice.

Authors:  Amir A Sadighi Akha; Andrew J McDermott; Casey M Theriot; Paul E Carlson; Charles R Frank; Roderick A McDonald; Nicole R Falkowski; Ingrid L Bergin; Vincent B Young; Gary B Huffnagle
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

8.  CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.

Authors:  Feng-Ting Liu; Jerome Giustiniani; Timothy Farren; Li Jia; Armand Bensussan; John G Gribben; Samir G Agrawal
Journal:  Blood       Date:  2010-02-17       Impact factor: 22.113

9.  Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation.

Authors:  Jérôme Giustiniani; Armand Bensussan; Anne Marie-Cardine
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

10.  CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

Authors:  John R Šedý; Ryan L Bjordahl; Vasileios Bekiaris; Matthew G Macauley; Brian C Ware; Paula S Norris; Nell S Lurain; Chris A Benedict; Carl F Ware
Journal:  J Immunol       Date:  2013-06-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.